Ligand id: 2018

Name: pasireotide

Structure and Physico-chemical Properties

2D Structure
No information available.
Summary of Clinical Use
Used to suppress levels of cortisol secretion in patients with Cushing’s disease.
Mechanism Of Action and Pharmacodynamic Effects
Pasireotide-induced activation of the somatostatin receptor causes inhibition of corticotropin secretion and therefore reduced cortisol levels in Cushing's disease patients.
External links